Duration and timing of bisphosphonate treatment as factors determining osteoblast mineralization
Background: Alendronate is a drug for the treatment of excessive bone resorption. Alendronate reduces osteoblast viability and mineralization in a dose-dependent manner. Other views of alendronate could affect mineralization. Therefore, the effects of timing and duration of alendronate treatment on...
Saved in:
Main Author: | Somying Patntirapong (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improvement of osteoblast adhesion, viability, and mineralization by restoring the cell cytoskeleton after bisphosphonate discontinuation in vitro
by: Somying PATNTIRAPONG, et al.
Published: (2024) -
Timing of geranylgeraniol addition increases osteoblast activities under alendronate condition
by: Harikarn Mungpayabarn, et al.
Published: (2021) -
Vanillin Promotes Osteoblast Differentiation, Mineral Apposition, and Antioxidant Effects in Pre-Osteoblasts
by: Hyung-Mun Yun, et al.
Published: (2024) -
Effect of bisphosphonate treatment of titanium surfaces on alkaline phosphatase activity in osteoblasts: a systematic review and meta-analysis
by: Christian Wehner, et al.
Published: (2020) -
Treatment of bisphosphonate induced osteonecrosis of jaw in rats using an angiogenesis factor (A-Heal) and ABMDO (Autologous Bone Marrow Derived Osteoblasts)
by: Mir Sadat-Ali, et al.
Published: (2022)